# An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

> **NCT04349111** · NA · WITHDRAWN · sponsor: **Xoft, Inc.**

## Conditions studied

- Invasive Ductal Carcinoma
- Ductal Carcinoma In Situ

## Interventions

- **RADIATION:** Intra-operative Radiation Therapy - IORT

## Key facts

- **NCT ID:** NCT04349111
- **Lead sponsor:** Xoft, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06-30
- **Primary completion:** 2033-12-31
- **Final completion:** 2034-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of site participation
- **Last updated:** 2022-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349111, "An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04349111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*